Specific research in women who use drugs is very scarce and treatments are not gender-sensitive oriented. For these reasons, it is important to guarantee access to the appropriate treatment of women who use drugs and a need for a gender perspective in the treatment and research of substance use disorders. The drug overdose death crisis in the United States has expanded and worsened over time, and is estimated to account for nearly 841,000 deaths since 1999 (CDC, 2021; Mattson et al., 2021). Opioids have contributed to significant increases in overdose deaths, starting in 1999 with prescription opioids and followed by waves involving heroin and then synthetic opioids (CDC, n.d.).
Social position and sociocultural context also affect the likelihood of experiencing alcohol problems, particularly negative social consequences, at a given level of consumption. Because these studies were based on older data that, in some cases, were collected nearly 20 years ago, data from the 2017 National Women and Alcoholism Survey on Drug Use and Health (NSDUH)15 were analyzed to provide updated national estimates for women. As shown in Table 1, most of the significant racial/ethnic differences in DSM-IV alcohol dependence prevalence were no longer apparent when abstainers were excluded.
While synthetic opioids (primarily illicitly manufactured fentanyl) continue to play a major role in overdose deaths, recent years have seen a significant increase in deaths involving stimulants like methamphetamine and cocaine (Mattson et al., 2021). For example, stimulant-involved overdose deaths have increased faster among Black/African American and American Indian and Alaska Native (AI/AN) populations compared to all other racial/ethnic groups (Kariisa et al., 2021). In addition, the opioid overdose death rate for Black/African American individuals increased by 38% from 2018 to 2019 in four U.S. states, while the rates for other racial/ethnic groups decreased or stayed the same in those same four states (Larochelle et al., 2021).
To treat these problems adequately, the relationship between a woman’s abuse history and substance use or co-occurring mental disorders must be determined. See TIP 36 Substance Abuse Treatment for Persons With Child Abuse and Neglect Issues (CSAT 2000b) for more information. A strong cultural prohibition exists against discussing family matters such as substance use or abuse during childhood, thus the use of psychoeducational groups to provide information on these topics may be more effective initially than therapy groups, where experiences are discussed openly. However, substance abuse counseling based on a family model often is well suited and is more culturally congruent for many Hispanics/Latinas.
In one study comparing differences in alcohol prevalence across age groups, ethnicity, and gender, prevalence rates among African-American females from 19 to 29 years of age rose from 2 percent to 4 percent between 1992 and 2002 (Grant et al. 2006). In a study evaluating the correlates of alcohol consumption of African-American women, women age 40 to 49 have shown the highest prevalence of alcohol consumption (Rosenberg et al. 2002). Research indicates that some Hispanics/Latinas generally maintain the cultural norms of their countries of origin and resist social pressures to engage in substance use (Mora 2002).
Substance use disorders (SUD) are complex and chronic diseases influenced by genetic, environmental, and social factors. Moreover, while one of three drug users is a woman, women continue to account for only one in five or fewer people in treatment 1. Many researchers indicate that these interactions are essential for improving education and awareness of risks. One of the most critical needs, however, seems to be the establishment or increase of facilities exclusively for women with addiction problems, as well as medical facilities for pregnant women or women with children, and above all, the adaptation of treatment programs to the specific needs of women 26,27,28,29,30,35,39. It is also important to introduce appropriate social, health, and care interventions for women suffering from drug addiction before and after drug treatment 5,23, if possible, with the introduction of interventions implemented by women for women 32. Of course, for these interventions to be implemented, adequate preparation of medical personnel is necessary, especially therapists’ high cultural competence, empathy, unconditional positive regard, and authenticity (Rogers’ triad) 25.
Terry D. Schneekloth, M.D., a Mayo Clinic psychiatrist with expertise in alcoholism and addiction, helps break down some of the differences. Receive free access to exclusive content, a personalized homepage based on your interests, and a weekly newsletter with topics of your choice. Studies of nicotine show a potential greater saliency in the luteal phase of the cycle, and women quitting during the luteal phase reported significantly greater increases in tobacco withdrawal and self-reported depressive symptoms than women quitting during the follicular phase 43, 44.